Preimplantation Genetics Diagnosis (PGD) Market

1
Preimplantation Genetics Diagnosis (PGD) Market
is Estimated to Reach 140 Million by 2024, Says
Variant Market Research
Dinesh Patel SEO Analyst help_at_variantmarketresear
ch.com
sales_at_variantmarketresearch.com
help_at_variantmarketresearch.com
2
DESCRIPTION - Preimplantation Genetics Diagnosis
(PGD) Market
Global Preimplantation Genetics Diagnosis (PGD)
Market is estimated to reach 140 Million by
2024 growing at a CAGR of 6.2 from 2016 to
2024. Preimplantation genetics diagnosis (PGD) is
a technique used for genetic profiling of embryos
before implantation to identify genetic defects
in embryos or even of oocytes.  It enables to
identify defects in embryos and aids in selecting
health embryos that are further used for
implanting in the uterus. It reduces the
frequency of unprompted abortion and doubles the
chances of delivering genetically healthy
baby. This technique can selectively avoid the
passing of hereditary disorders that prevails in
the family into a newborn baby. Currently, PGD is
the only technique available which are used to
avoid highly affected embryo before
implantation. Browse Complete Report _at_
https//www.variantmarketresearch.com/report-categ
ories/medical-devices/preimplantation-genetics-dia
gnosis-market
sales_at_variantmarketresearch.com
help_at_variantmarketresearch.com
3
Global Preimplantation Genetics Diagnosis (PGD)
Market Size and Forecast, 2015 - 2024
sales_at_variantmarketresearch.com
help_at_variantmarketresearch.com
4
Global Preimplantation Genetics Diagnosis (PGD)
market
Declining fertility rate globally, development of
advanced technologies in the field of genetic
analysis, and growing occurrence of genetic
disorders are the drivers boosting the growth of
the global preimplantation genetics diagnosis
market. Moreover, increasing rate in the adoption
of IVF, and rising possibility of genetic
abnormalities in embryos with progressing
maternal age also supports the growth of the
market. However, stringent government
regulations, and social-economic concerns would
severally hamper the adoption among end users.
Furthermore, increasing RD and market expansion
would provide future scope for the market in the
coming years. The global preimplantation genetics
diagnosis (PGD) is segmented on the basis of test
type and geography. Test type is further
bifurcated as gender selection, chromosomal
abnormalities, single gene disorders, HLA typing,
aneuploidy, X-linked diseases, and other
types. Get Sample Report _at_ https//www.variantmark
etresearch.com/report-categories/medical-devices/p
reimplantation-genetics-diagnosis-market/sample-re
quest
sales_at_variantmarketresearch.com
help_at_variantmarketresearch.com
5
Global Preimplantation Genetics Diagnosis (PGD)
market share by region, 2024 
sales_at_variantmarketresearch.com
help_at_variantmarketresearch.com
6
The Major Key Players

•  Abbott Laboratories
• Natera, Inc.
• PerkinElmer, Inc.
• Illumina, Inc.
• F. Hoffmann-La Roche AG
• Thermo Fisher Scientific, Inc.
• Agilent Technologies, Inc.
• PerkinElmer, Inc.
• Cooper Surgical, Inc.
• Beijing Genomics Institute (BGI) 

sales_at_variantmarketresearch.com
help_at_variantmarketresearch.com
7
The key takeaways from the report

• The report will provide detailed analysis of
  Preimplantation Genetics Diagnosis (PGD) Market
  with respect to major segments such as test type,
  and geography
• The report will include the qualitative and
  quantitative analysis with market estimation over
  2015-2024 and compound annual growth rate (CAGR)
  between 2016 and 2024
• Comprehensive analysis of market dynamics
  including factors and opportunities will be
  provided in the report
• An exhaustive regional analysis of
  Preimplantation Genetics Diagnosis (PGD) Market
  has been included in the report
• Profile of the key players in the Preimplantation
  Genetics Diagnosis (PGD) Market will be provided,
  which include key financials, product services,
  new developments and business strategies

sales_at_variantmarketresearch.com
help_at_variantmarketresearch.com
8
Scope of Preimplantation Genetics Diagnosis (PGD)
Market

• Test Type Segments
• Gender Selection
• Chromosomal Abnormalities
• Single Gene Disorders
• HLA Typing
• Aneuploidy
• X-Linked Diseases
• Other Test Types

sales_at_variantmarketresearch.com
help_at_variantmarketresearch.com
9
Table Of Content
Chapter 1 Prefix 1.1 Market Scope 1.2
Report Description 1.3 Research Methodology
1.3.1 Primary Research 1.3.2
Secondary Research 1.3.3 In-house Data
Modeling Chapter 2 Executive Summary
Chapter 3 Market Outline 3.1 Market
Inclination, Trend, Outlook and Viewpoint 3.2
Market Share Analysis Companys Competitive
Scenario 3.3 Market Dynamics 3.3.1
Drivers 3.3.1.1 Impact
Analysis 3.3.2 Restraints
3.3.2.1 Impact Analysis 3.3.3
Opportunities ..
sales_at_variantmarketresearch.com
help_at_variantmarketresearch.com
10
Table Of Content
Chapter 6 Company Profiles 6.1 Abbott
Laboratories 6.2 Natera, Inc. 6.3
PerkinElmer, Inc. 6.4 Illumina, Inc. 6.5
F. Hoffmann-La Roche AG 6.6 Thermo Fisher
Scientific, Inc. 6.7 Agilent Technologies,
Inc. 6.8 PerkinElmer, Inc. 6.9 Cooper
Surgical, Inc. 6.10 Beijing Genomics
Institute (BGI)
sales_at_variantmarketresearch.com
help_at_variantmarketresearch.com
11
CONTACT US
Web https//www.variantmarketresearch.com
Michael Mendes Head - Sales Variant Market
Research 649 Mission St, 5th Floor, San
Francisco, CA 94105, United States. Tel
1-415-680-2785 Fax [phone] Email
michael.mendes_at_variantmarketresearch.com
Email help_at_variantmarketresearch.com
sales_at_variantmarketresearch.com
help_at_variantmarketresearch.com
12
THANK YOU .
FOLLOW US
Sample Request
LinkedIn
Twitter
Google Plus
Facebook
sales_at_variantmarketresearch.com
help_at_variantmarketresearch.com
sales_at_variantmarketresearch.com
help_at_variantmarketresearch.com